The FDA expects to issue a final rule to harmonize the agency’s regulations on human subject protection and IRBs with the revised Common Rule in the next few months, according to the federal Unified Agenda released in September. The FDA released the notice of proposed rulemaking (NPRM) in September 2022, four years after the Department of Health and Human Services revised the... Read More